Literature DB >> 23591102

Estimating vaccine effectiveness against severe influenza in England and Scotland 2011/2012: applying the screening method to data from intensive care surveillance systems.

H L Thomas1, N Andrews, H K Green, N L Boddington, H Zhao, A Reynolds, J McMenamin, R G Pebody.   

Abstract

Methods for estimating vaccine effectiveness (VE) against severe influenza are not well established. We used the screening method to estimate VE against influenza resulting in intensive care unit (ICU) admission in England and Scotland in 2011/2012. We extracted data on confirmed influenza ICU cases from severe influenza surveillance systems, and obtained their 2011/2012 trivalent influenza vaccine (TIV) status from primary care. We compared case vaccine uptake with population vaccine uptake obtained from routine monitoring systems, adjusting for age group, specific risk group, region and week. Of 60 influenza ICU cases reported, vaccination status was available for 56 (93%). Adjusted VE against ICU admission for those aged ≥ 65 years was -10% [95% confidence interval (CI) -207 to 60], consistent with evidence of poor protection from the 2011/2012 TIV in 2011/2012. Adjusted VE for those aged <65 years in risk groups was -296% (95% CI -930 to -52), suggesting significant residual confounding using the screening method in those subject to selective vaccination.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23591102      PMCID: PMC9152609          DOI: 10.1017/S0950268813000824

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  19 in total

1.  Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly.

Authors:  D A Foster; A Talsma; A Furumoto-Dawson; S E Ohmit; J R Margulies; N H Arden; A S Monto
Journal:  Am J Epidemiol       Date:  1992-08-01       Impact factor: 4.897

2.  Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12.

Authors:  E Kissling; M Valenciano
Journal:  Euro Surveill       Date:  2012-04-12

3.  Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks.

Authors:  Marta Valenciano; Esther Kissling; Bruno Christian Ciancio; Alain Moren
Journal:  Vaccine       Date:  2010-09-17       Impact factor: 3.641

4.  Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study.

Authors:  E Kissling; M Valenciano
Journal:  Euro Surveill       Date:  2011-03-17

5.  Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection.

Authors:  R G Pebody; N Andrews; J McMenamin; H Durnall; J Ellis; C I Thompson; C Robertson; S Cottrell; B Smyth; M Zambon; C Moore; D M Fleming; J M Watson
Journal:  Euro Surveill       Date:  2013-01-31

6.  Estimation of vaccine effectiveness using the screening method.

Authors:  C P Farrington
Journal:  Int J Epidemiol       Date:  1993-08       Impact factor: 7.196

7.  Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008-2010: results from a cohort study in general practice.

Authors:  Pia Hardelid; Douglas M Fleming; Nick Andrews; Michele Barley; Hayley Durnall; Punam Mangtani; Richard Pebody
Journal:  Vaccine       Date:  2011-12-16       Impact factor: 3.641

8.  Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls.

Authors:  Wiebke Hellenbrand; Pernille Jorgensen; Brunhilde Schweiger; Gerhard Falkenhorst; Matthias Nachtnebel; Benedikt Greutélaers; Christian Traeder; Ole Wichmann
Journal:  BMC Infect Dis       Date:  2012-05-31       Impact factor: 3.090

9.  Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom.

Authors:  R G Pebody; N Andrews; D M Fleming; J McMenamin; S Cottrell; B Smyth; H Durnall; C Robertson; W Carman; J Ellis; P Sebastian-Pillai; M Zambon; C Kearns; C Moore; D Rh Thomas; J M Watson
Journal:  Epidemiol Infect       Date:  2012-06-13       Impact factor: 4.434

10.  A new sentinel surveillance system for severe influenza in England shows a shift in age distribution of hospitalised cases in the post-pandemic period.

Authors:  Shelly Bolotin; Richard Pebody; Peter J White; James McMenamin; Luke Perera; Jonathan S Nguyen-Van-Tam; Thomas Barlow; John M Watson
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

View more
  8 in total

1.  Early estimates of 2014/15 seasonal influenza vaccine effectiveness in preventing influenza-like illness in general practice using the screening method in France.

Authors:  Cécile Souty; Thierry Blanchon; Isabelle Bonmarin; Daniel Lévy-Bruhl; Sylvie Behillil; Vincent Enouf; Martine Valette; Maude Bouscambert; Clément Turbelin; Lisandru Capai; Victoire Roussel; Thomas Hanslik; Alessandra Falchi
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 2.  Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies.

Authors:  Marc Rondy; Nathalie El Omeiri; Mark G Thompson; Alain Levêque; Alain Moren; Sheena G Sullivan
Journal:  J Infect       Date:  2017-09-18       Impact factor: 6.072

3.  Influenza vaccination status and outcomes among influenza-associated hospitalizations in Columbus, Ohio (2012-2015).

Authors:  P N Zivich; L Tatham; K Lung; J Tien; C E Bollinger; J K Bower
Journal:  Epidemiol Infect       Date:  2017-10-16       Impact factor: 4.434

4.  Application of the screening method to monitor influenza vaccine effectiveness among the elderly in Germany.

Authors:  Cornelius Remschmidt; Thorsten Rieck; Birte Bödeker; Ole Wichmann
Journal:  BMC Infect Dis       Date:  2015-03-20       Impact factor: 3.090

5.  Influenza vaccine effectiveness in preventing influenza A(H3N2)-related hospitalizations in adults targeted for vaccination by type of vaccine: a hospital-based test-negative study, 2011-2012 A(H3N2) predominant influenza season, Valencia, Spain.

Authors:  Joan Puig-Barberà; Juan García-de-Lomas; Javier Díez-Domingo; Alberto Arnedo-Pena; Montserrat Ruiz-García; Ramón Limón-Ramírez; Silvia Pérez-Vilar; José Luis Micó-Esparza; Miguel Tortajada-Girbés; Concha Carratalá-Munuera; Rosa Larrea-González; Juan Manuel Beltrán-Garrido; Maria Del Carmen Otero-Reigada; Joan Mollar-Maseres; Patricia Correcher-Medina; Germán Schwarz-Chavarri; Vicente Gil-Guillén
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

6.  Live attenuated influenza vaccine effectiveness against hospitalisation due to laboratory-confirmed influenza in children two to six years of age in England in the 2015/16 season.

Authors:  Richard Pebody; Bersabeh Sile; Fiona Warburton; Mary Sinnathamby; Camille Tsang; Hongxin Zhao; Joanna Ellis; Nick Andrews
Journal:  Euro Surveill       Date:  2017-01-26

7.  Varicella vaccine dose depended effectiveness and waning among preschool children in Hong Kong.

Authors:  Yung-Wai Desmond Chan; W John Edmunds; Hong-Lam Chan; Miu-Ling Wong; Ka-Wing Albert Au; Shuk-Kwan Chuang; Albert Jan van Hoek; Stefan Flasche
Journal:  Hum Vaccin Immunother       Date:  2019-10-23       Impact factor: 3.452

8.  Live-attenuated influenza vaccine effectiveness against hospitalization in children aged 2-6 years, the first three seasons of the childhood influenza vaccination program in England, 2013/14-2015/16.

Authors:  Nicki L Boddington; Punam Mangtani; Hongxin Zhao; Neville Q Verlander; Joanna Ellis; Nick Andrews; Richard G Pebody
Journal:  Influenza Other Respir Viruses       Date:  2022-05-09       Impact factor: 5.606

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.